Patheon to manufacture amyloidosis antibody treatment for Caelum
Caelum Biosciences has selected Patheon to make its lead antibody CAEL-101 to treat orphan disease amyloid light-chain (AL) amyloidosis.
Caelum Biosciences has selected Patheon to make its lead antibody CAEL-101 to treat orphan disease amyloid light-chain (AL) amyloidosis.
India's largest polyester-based packaging film company Jindal Poly Films Ltd (JPFL) is allegedly in talks to buy the European production assets of DuPont Teijin Films (DTF) for an estimated $300m.